Bruno Daniele
ORCID：0000-0002-2638-3156
发表论文 371 篇 · 总被引 19365 次 · h-index 50
代表论文
- Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (2024 · Annals of Oncology · 被引 347)
- Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors (2024 · JAMA Network Open · 被引 48)
- Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study (2024 · Targeted Oncology · 被引 28)
- Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial (2025 · ESMO Open · 被引 18)
- The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers (2025 · Cancer Treatment Reviews · 被引 15)
- Rare epithelial gastric cancers: a review of the current treatment knowledge (2025 · Therapeutic Advances in Medical Oncology · 被引 9)